NCT07318740

Brief Summary

This randomized controlled trial aims to evaluate the impact of mobile application-supported education and counseling on the intention, attitude, behavior, and self-efficacy of pregnant women diagnosed with gestational diabetes. The study will be conducted at Ankara Bilkent City Hospital, with participants assigned to intervention and control groups. The intervention group will receive planned education and counseling via a mobile application, while the control group will receive standard hospital education. Data will be collected at predetermined intervals, and outcomes will be compared between the groups. The study seeks to determine the effectiveness of a mobile application-supported approach in the management of gestational diabetes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 18, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 26, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 6, 2026

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 26, 2025

Last Update Submit

January 4, 2026

Conditions

Keywords

Gestational DiabetesNursingMobile ApplicationMotivationSelf-Efficacy

Outcome Measures

Primary Outcomes (1)

  • Change in Gestational Diabetes Intention, Attitude, and Behavior Scale (GDNTD-Ö) Scores

    This measure uses the validated Turkish adaptation of the Diabetes Intention, Attitude, and Behavior Scale. The instrument contains 14 items across 5 subdimensions. Total scores are transformed to a 0-100 scale, with higher scores indicating stronger intention, attitude, and behavior for self-management in gestational diabetes. There is no defined cut-off value. Measurement will be based on the self-administered GDNTD-Ö questionnaire.

    Baseline (before education), 3 weeks after completion of the 2-week education program (first follow-up), and 2 weeks after this first follow-up (second follow-up).

Secondary Outcomes (1)

  • Change in Gestational Diabetes Self-Efficacy Scale (GESGD) Scores

    Baseline (before education), 3 weeks after completion of the 2-week education program (first follow-up), and 2 weeks after this first follow-up (second follow-up).

Other Outcomes (1)

  • Mobile Health Applications Adoption Scale Score (Intervention Group Only)

    Second (final) follow-up, conducted 2 weeks after the first follow-up.

Study Arms (2)

Mobile Application-Based Education and Counseling

EXPERIMENTAL

Participants will receive a two-week structured education and counseling program via the SugarMoms mobile application for gestational diabetes management. The program, delivered by a certified diabetes nurse educator, covers topics including gestational diabetes management, blood glucose monitoring, insulin therapy, management of hypoglycemia and hyperglycemia, nutrition, physical activity, and pregnancy health recommendations. Each module includes audio support, a question-and-answer component, and daily motivational notifications (e.g., exercise, diet, hydration). Participants will record their daily blood glucose, dietary intake, and physical activity in the app. After completing the two-week program, participants will continue daily use of the app during the study. Follow-up assessments and questionnaires will also be administered through the app. Progress, logs, and module completion will be monitored via the administrator panel.

Behavioral: Mobile Application-Based Education and Counseling Program

Standard Face-to-Face Gestational Diabetes Education

ACTIVE COMPARATOR

Participants will receive a two-week standard face-to-face gestational diabetes education program provided by a certified diabetes nurse educator in accordance with the hospital protocol. The content will parallel the topics included in the intervention group's mobile application program. Blood glucose monitoring will be recorded using paper-based forms.

Behavioral: Standard Face-to-Face Gestational Diabetes Education

Interventions

A two-week structured education and counseling program delivered via the SugarMoms mobile application for gestational diabetes management. Education is provided by a certified diabetes nurse educator and includes topics such as gestational diabetes management, blood glucose monitoring, insulin therapy, management of hypo/hyperglycemia, healthy nutrition, physical activity, and pregnancy health recommendations. Each module includes audio support, a question-and-answer component, and daily motivational notifications. Participants will log daily blood glucose, dietary intake, and physical activity in the app and continue app use throughout the study. Follow-up assessments and questionnaires are delivered through the app, and progress is monitored via the administrator panel.

Mobile Application-Based Education and Counseling

A two-week standard face-to-face gestational diabetes education program provided by a certified diabetes nurse educator in accordance with hospital protocol. The program covers the same topics as the intervention group's app-based program. Blood glucose monitoring is recorded using paper-based forms.

Standard Face-to-Face Gestational Diabetes Education

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women aged ≥18 years.
  • Minimum education level: primary school graduate.
  • Singleton pregnancy.
  • No prior diagnosis of gestational diabetes mellitus (GDM).
  • Newly diagnosed with GDM based on oral glucose tolerance test (OGTT) results.
  • Currently receiving insulin treatment as part of the clinical management plan.
  • Absence of comorbid conditions such as hypertension, preeclampsia, or other chronic diseases.
  • Ability to read and understand Turkish.
  • Ownership of a smartphone (iOS/Android) with internet access.
  • Willingness to participate and provide written informed consent.

You may not qualify if:

  • Development of pregnancy-related complications during the follow-up period.
  • Incomplete or missing data in the study forms.
  • Non-compliance with study protocol.
  • Withdrawal from the study at the participant's request.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, 06170, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Gönül Kurt, Assoc. Prof. Dr.

    University of Health Sciences, Gülhane Faculty of Nursing, Department of Obstetrics and Gynecology Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2025

First Posted

January 6, 2026

Study Start

August 18, 2025

Primary Completion

November 30, 2025

Study Completion

February 1, 2026

Last Updated

January 6, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) will be shared. Supporting documents such as the study protocol, statistical analysis plan, and informed consent form may also be provided.

Shared Documents
STUDY PROTOCOL
Time Frame
12 months after publication
Access Criteria
De-identified IPD will be available upon reasonable request to the Principal Investigator, conditional on signing a data sharing agreement.

Locations